Description

The Cardiac Marker Test YRA363 // YRA367 offers cutting-edge solutions for early detection and monitoring of cardiac events. Utilizing enzymatic chemiluminescence technology and ALP as a luminous marker, these tests provide high sensitivity and exceptional stability. They’re compatible with CLIA Analyzers, ensuring seamless integration for laboratories seeking reliable and rapid results. With a focus on precision and efficiency, this product stands out in cardiovascular diagnostics.

Market Price

In the competitive landscape of cardiac diagnostic tools, the Cardiac Marker Test YRA363 // YRA367 is positioned within the mid to high range, reflecting its advanced technology and reliability. Prices can vary from $600 to $1,200 per kit, depending on suppliers, quantity, and purchasing agreements. For the best pricing options, consider engaging with our sales experts or generate a quote automatically through the Kalstein Plus platform.

Frequently Asked Questions

What is the primary use of the Cardiac Marker Test YRA363 // YRA367? This test is mainly used for diagnosing and monitoring conditions like heart failure, myocardial infarction, and other cardiac events using biomarkers such as NT-ProBNP and hs-cTnI.

How many tests can each kit perform? Each kit offers configurations of 48, 50, or 100 tests, providing flexibility depending on laboratory needs.

Are there specific storage requirements? Yes, it is crucial to store the kits at temperatures between 2-8°C to maintain reagent stability and performance integrity.

Advantages and Disadvantages

The Cardiac Marker Test YRA363 // YRA367 has numerous advantages including high sensitivity, precise results, and compatibility with automated systems. It minimizes manual intervention and potential human error. However, a possible disadvantage could be the requirement for specific analyzer compatibility, limiting its use to facilities with the necessary equipment.

Product Use in the Field

In clinical settings, the Cardiac Marker Test YRA363 // YRA367 is utilized for rapid assessment of cardiac health, particularly in emergency rooms and intensive care units. The quick operation and automation capabilities allow healthcare providers to make timely, informed decisions about patient care, ultimately improving treatment outcomes.

Recommendations

To maximize the benefits of the Cardiac Marker Test YRA363 // YRA367, always adhere to suggested storage conditions and use the product with compatible analyzers. Regular calibration and maintenance of equipment are recommended to ensure optimal performance and accuracy in test results. For comprehensive solutions and guidance, connect with the Kalstein Plus platform for expert support and automated quotations.

Specifications